Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved t...
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its two Pernix sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc. To learn more about Pernix Therapeutics, visit www.pernixtx.com.
Public Symbol
PTX
Founded Year
1997
Organization Website
pernixtx.com
Organization Languages
English
Organization Revenue
140900
Current Technologies
outlook
office 365
godaddy hosting
omniture adobe
zendesk
adobe tag management
asp net
wordpress org
google maps
google universal analytics
apache
google analytics
mobile friendly
Job Functions
Sales
Finance
Human Resources
Consulting
Operations
Business Development
Legal
Marketing
Accounting
Product Management
Media And Commmunication
Support
Information Technology
pharmaceuticals
biotechnology
pharmaceutical
health care
medical
health
wellness & fitness
Angus Smith's Work History and Education
Pernix Therapeutics
Vice President, Business Development & Strategic Planning